agilon health, inc. filed a Form 8-K on November 16, 2026, disclosing plans to host a virtual investor event and presentation on November 17, 2026, at 2:00 PM Eastern Time.

Key Highlights

  • Event date and time: The virtual investor presentation is scheduled for Tuesday, November 17, 2026, at 2:00 PM Eastern Time.
  • Exhibit filed: An investor presentation dated November 17, 2026, was furnished as Exhibit 99.1 and incorporated by reference.
  • Regulation FD: The disclosure was made under Item 7.01, Regulation FD Disclosure.
  • Signing officer: The filing was signed by Jeffrey Schwaneke, Chief Financial Officer of agilon health, inc.
  • Not "filed" for liability purposes: According to the filing, the Item 7.01 information "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934."

agilon health Announces Virtual Investor Presentation for November 17

agilon health, inc. (NYSE:AGL), a Delaware-incorporated company principally focused on enabling primary care physicians to serve Medicare patients through a full-risk, global capitation model, submitted a current report on November 16, 2026, to inform investors of an upcoming virtual event. According to the filing, the company will host the presentation on November 17, 2026, beginning at 2:00 PM Eastern Time, with a simultaneous webcast available through the company's investor relations website.

The filing states that replays of the presentation will be available for on-demand listening shortly after the event concludes. The investor presentation itself was furnished as Exhibit 99.1 and is described in the filing as an investor presentation dated November 17, 2026. The report was signed by Jeffrey Schwaneke in his capacity as Chief Financial Officer, indicating his authorization of the disclosure on behalf of the registrant.

The filing notes that the furnished information under Item 7.01 and the related Exhibit 99.1 "shall not be incorporated by reference in any filing with, the Securities and Exchange Commission under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference therein." The company's common stock, par value $0.01 per share, is listed on The New York Stock Exchange under the trading symbol AGL.

What Was Disclosed

agilon health, inc. filed an 8-K on November 16, 2026, under Regulation FD to announce a virtual investor event scheduled for November 17, 2026, at 2:00 PM Eastern Time, and to furnish an accompanying investor presentation as Exhibit 99.1.